Spinal cord compression in mycosis fungoides
نویسندگان
چکیده
منابع مشابه
Successful cord blood transplantation for mycosis fungoides.
A 26-year-old female diagnosed as mycosis fungoides (MF, clinical stage IV) was treated with single-agent chemotherapy, multi-drug chemotherapy and unrelated bone marrow transplantation with reduced-intensity conditioning (engraftment failure), resulting in failure. Unrelated cord blood transplantation (CBT) as second transplantation following myeloablative conditioning brought complete remissi...
متن کامل[Mycosis fungoides].
History A middle-aged male with a 10-year-history of generalized pruritus involving the whole body was seen in a skin clinic. He denied any significant past medical or drug history. He had no known allergy. Previous skin biopsy performed over the abdomen in February 1999 showed features of lichen planus. He was treated with various topical steroids, emollients and antihistamines but the skin ra...
متن کاملMycosis Fungoides and Variants
The most common cutaneous lymphoma is known historically as mycosis fungoides (MF), and represents about 50-60% of all cutaneous lymphomas. The broader term “cutaneous T-cell lymphoma” has also been applied to mycosis fungoides and related conditions such as Sezary syndrome, but it is important to recognize that there are several forms of T-cell lymphoma in the skin unrelated to mycosis fungoid...
متن کاملMycosis fungoides: therapeutic difficulties.
404 Lymphoma belongs to a heterogeneous group of malignant neoplasms of the lymphatic system developing from lymphocytes, precursor cells, or directly from a multipotent stem cell [1]. Cutaneous T-cell lymphoma (CTCL), including mycosis fungoides, first affects the skin [2]. Mycosis fungoides, first described by Albert in 1806, is a type of lymphoma developing from peripheral T cells, character...
متن کاملHealth disparities in mycosis fungoides
Mycosis fungoides, the most common form of cutaneous T-cell lymphoma, has a higher incidence and poorer prognosis in African-Americans. The factors that may be contributing to this disparity are presented in the context of a health disparities framework that includes discussion of patient-related factors such as race/ethnicity, socioeconomic status, and biological differences, provider-related ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Cancer
سال: 1982
ISSN: 0008-543X,1097-0142
DOI: 10.1002/1097-0142(19821201)50:11<2510::aid-cncr2820501142>3.0.co;2-i